Borovikova Anna A, Ziegler Mary E, Banyard Derek A, Wirth Garrett A, Paydar Keyianoosh Z, Evans Gregory R D, Widgerow Alan David
From the Center for Tissue Engineering, University of California, Irvine, Irvine, CA.
Ann Plast Surg. 2018 Mar;80(3):297-307. doi: 10.1097/SAP.0000000000001278.
Treatment of hypertrophic scars and other fibrotic skin conditions with autologous fat injections shows promising clinical results; however, the underlying mechanisms of its antifibrotic action have not been comprehensively studied. Adipose-derived stem cells, or stromal cell-derived factors, inherent components of the transplanted fat tissue, seem to be responsible for its therapeutic effects on difficult scars. The mechanisms by which this therapeutic effect takes place are diverse and are mostly mediated by paracrine signaling, which switches on various antifibrotic molecular pathways, modulates the activity of the central profibrotic transforming growth factor β/Smad pathway, and normalizes functioning of fibroblasts and keratinocytes in the recipient site. Direct cell-to-cell communications and differentiation of cell types may also play a positive role in scar treatment, even though they have not been extensively studied in this context. A more thorough understanding of the fat tissue antifibrotic mechanisms of action will turn this treatment from an anecdotal remedy to a more controlled, timely administered technology.
用自体脂肪注射治疗增生性瘢痕和其他纤维化皮肤病显示出有前景的临床结果;然而,其抗纤维化作用的潜在机制尚未得到全面研究。脂肪来源的干细胞或基质细胞衍生因子是移植脂肪组织的固有成分,似乎对其治疗难治性瘢痕的效果负责。这种治疗效果发生的机制多种多样,主要由旁分泌信号介导,旁分泌信号开启各种抗纤维化分子途径,调节中心促纤维化转化生长因子β/Smad途径的活性,并使受体部位的成纤维细胞和角质形成细胞功能正常化。尽管在这种情况下尚未对细胞间直接通讯和细胞类型分化进行广泛研究,但它们在瘢痕治疗中也可能发挥积极作用。更深入地了解脂肪组织的抗纤维化作用机制将使这种治疗从一种经验性疗法转变为一种更可控、适时应用的技术。